908 Devices Inc.
NASDAQ:MASS
Intrinsic Value
908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. [ Read More ]
The intrinsic value of one MASS stock under the Base Case scenario is 4.59 USD. Compared to the current market price of 5.5 USD, 908 Devices Inc. is Overvalued by 17%.
Valuation Backtest
908 Devices Inc.
Run backtest to discover the historical profit from buying and selling MASS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
908 Devices Inc.
Current Assets | 173.8m |
Cash & Short-Term Investments | 145.7m |
Receivables | 9m |
Other Current Assets | 19.1m |
Non-Current Assets | 29.2m |
PP&E | 9.6m |
Intangibles | 18.2m |
Other Non-Current Assets | 1.4m |
Current Liabilities | 22.5m |
Accounts Payable | 1.2m |
Accrued Liabilities | 10.7m |
Other Current Liabilities | 10.6m |
Non-Current Liabilities | 14.9m |
Other Non-Current Liabilities | 14.9m |
Earnings Waterfall
908 Devices Inc.
Revenue
|
50.2m
USD
|
Cost of Revenue
|
-24.9m
USD
|
Gross Profit
|
25.3m
USD
|
Operating Expenses
|
-68.1m
USD
|
Operating Income
|
-42.8m
USD
|
Other Expenses
|
6.4m
USD
|
Net Income
|
-36.4m
USD
|
Free Cash Flow Analysis
908 Devices Inc.
MASS Profitability Score
Profitability Due Diligence
908 Devices Inc.'s profitability score is 22/100. The higher the profitability score, the more profitable the company is.
Score
908 Devices Inc.'s profitability score is 22/100. The higher the profitability score, the more profitable the company is.
MASS Solvency Score
Solvency Due Diligence
908 Devices Inc.'s solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Score
908 Devices Inc.'s solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MASS Price Targets Summary
908 Devices Inc.
According to Wall Street analysts, the average 1-year price target for MASS is 15.64 USD with a low forecast of 14.14 USD and a high forecast of 17.85 USD.
Ownership
MASS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
MASS Price
908 Devices Inc.
Average Annual Return | 16.51% |
Standard Deviation of Annual Returns | 136.37% |
Max Drawdown | -93% |
Market Capitalization | 178.9m USD |
Shares Outstanding | 32 909 900 |
Percentage of Shares Shorted | 5.49% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. The company is headquartered in Boston, Massachusetts and currently employs 177 full-time employees. The company went IPO on 2020-12-18. The firm's Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel and ZipChip. MX908 is a handheld Mass Spec device designed for analysis of gas, liquid and solid materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a desktop analyzer providing real-time information on the extracellular environment in bioprocesses. ZipChip is a plug-and-play separation platform that optimizes Mass Spec sample analysis.
Contact
IPO
Employees
Officers
The intrinsic value of one MASS stock under the Base Case scenario is 4.59 USD.
Compared to the current market price of 5.5 USD, 908 Devices Inc. is Overvalued by 17%.